Theratechnologies
THTX
THTX was delisted on the 25th of September, 2025.
33 hedge funds and large institutions have $20.2M invested in Theratechnologies in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.3% more ownership
Funds ownership: 30.99% → 31.29% (+0.3%)
0% more funds holding
Funds holding: 33 → 33 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
14% less capital invested
Capital invested by funds: $23.6M → $20.2M (-$3.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWP
Cyndeo Wealth Partners
St. Petersburg,
Florida
|
+$138K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$64.3K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$11.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.26K |
| 5 |
CFD
Creative Financial Designs
Kokomo,
Indiana
|
+$995 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$31.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.33K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.84K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$841 |
| 5 |
TC
Truvestments Capital
Sarasota,
Florida
|
-$495 |
THTX Hedge Fund Activity: Q2 2024 in Review
33 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q2 2024, worth a combined $20.2M — down 14% from $23.6M a quarter earlier.
Fund positioning in THTX was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Cyndeo Wealth Partners, opening a new position worth an estimated $138K. The largest seller was Citadel Advisors, exiting entirely with an estimated $31.9K sold.
- 33 institutional investors held Theratechnologies (THTX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $20.2M of Theratechnologies stock for Q2 2024, down 14% quarter-over-quarter.
- 2 funds opened new Theratechnologies positions in Q2 2024 and 2 closed out, a net change of 0 holders.
- The largest Theratechnologies buyer in Q2 2024 was Cyndeo Wealth Partners, an estimated $138K added.
- The largest Theratechnologies seller in Q2 2024 was Citadel Advisors, an estimated $31.9K sold.
Based on aggregated 13F filings for Q2 2024.